Scholarlink

Objective <p>Assess the efficacy of routine ETCOc for all newborns in managing neonatal hyperbilirubinemia.</p> Study design <p>Retrospective chart review of 1029 consecutive well-baby nursery admissions following the 2022 AAP hyperbilirubinemia guidelines. Only ETCOc, not type, Rh, and DAT, was used to determine if significant hemolysis was present in sufficient degree to affect bilirubin management. A cost-benefit analysis comparing the two methods was conducted.</p> Result <p>2.8% of infants required phototherapy, and 1.1% were readmitted for hyperbilirubinemia. The closer an infant’s bilirubin level was to the phototherapy threshold, the higher the ETCOc. 12 of 29 DAT negative infants with ETCOc ≥ 2.5 PPM who received phototherapy would have gone home with significant hemolysis at risk for readmission or kernicterus if not for the use of ETCOc.</p> Conclusion <p>ETCOc is preferable for assessing significant hemolysis in the newborn, can be used to safely manage newborn hyperbilirubinemia, and results in cost savings.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

End-tidal carbon monoxide for routine monitoring of significant hemolysis in the management of newborn hyperbilirubinemia

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年2月26日

查看全文
  • Shanice Wells,
  • Ramya Balasubramanian,
  • Khang Nguyen,
  • David L. Schutzman

摘要

Objective

Assess the efficacy of routine ETCOc for all newborns in managing neonatal hyperbilirubinemia.

Study design

Retrospective chart review of 1029 consecutive well-baby nursery admissions following the 2022 AAP hyperbilirubinemia guidelines. Only ETCOc, not type, Rh, and DAT, was used to determine if significant hemolysis was present in sufficient degree to affect bilirubin management. A cost-benefit analysis comparing the two methods was conducted.

Result

2.8% of infants required phototherapy, and 1.1% were readmitted for hyperbilirubinemia. The closer an infant’s bilirubin level was to the phototherapy threshold, the higher the ETCOc. 12 of 29 DAT negative infants with ETCOc ≥ 2.5 PPM who received phototherapy would have gone home with significant hemolysis at risk for readmission or kernicterus if not for the use of ETCOc.

Conclusion

ETCOc is preferable for assessing significant hemolysis in the newborn, can be used to safely manage newborn hyperbilirubinemia, and results in cost savings.